Clearmind Medicine, Inc. (CMND)
1.67
-0.01
(-0.60%)
USD |
NASDAQ |
Aug 25, 09:44
Clearmind Medicine Total Liabilities (Quarterly) : 3.033M for April 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | 3.033M |
| January 31, 2026 | 2.905M |
| October 31, 2025 | 4.890M |
| July 31, 2025 | 2.904M |
| April 30, 2025 | 2.879M |
| January 31, 2025 | 3.731M |
| October 31, 2024 | 4.148M |
| July 31, 2024 | 4.700M |
| April 30, 2024 | 4.20M |
| January 31, 2024 | 5.056M |
| October 31, 2023 | 4.970M |
| July 31, 2023 | 1.661M |
| April 30, 2023 | 2.654M |
| January 31, 2023 | 0.8032M |
| October 31, 2022 | 1.934M |
| July 31, 2022 | 0.6112M |
| April 30, 2022 | 0.1936M |
| Date | Value |
|---|---|
| January 31, 2022 | 0.1508M |
| October 31, 2021 | 0.2881M |
| July 31, 2021 | 0.3523M |
| April 30, 2021 | 0.0231M |
| January 31, 2021 | 0.0252M |
| October 31, 2020 | 0.01M |
| July 31, 2020 | 0.011M |
| April 30, 2020 | 0.0187M |
| January 31, 2020 | 0.0522M |
| October 31, 2019 | 0.0339M |
| July 31, 2019 | 0.0233M |
| April 30, 2019 | 0.0215M |
| January 31, 2019 | 0.0016M |
| October 31, 2018 | 0.0058M |
| July 31, 2018 | 0.0491M |
| April 30, 2018 | 0.0505M |
| January 31, 2018 | 0.0536M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | 2.242M |
| NervGen Pharma Corp. | 51.39M |
| Milestone Pharmaceuticals, Inc. | 163.41M |
| Lexaria Bioscience Corp. | 0.4371M |
| Target Group, Inc. (Canada) | 14.33M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.52M |
| Shareholders Equity (Quarterly) | 11.49M |
| Debt to Equity Ratio | 0.0075 |
| Current Ratio | 4.793 |
| Net Debt Paydown Yield | -0.11% |